Le Lézard
Classified in: Health
Subjects: LEG, CFG

Regulations for Monitoring Medical Assistance in Dying Come into Force


The regulations will come into force November 1, 2018

OTTAWA, Aug. 9, 2018 /CNW/ - The Government of Canada recognizes that medical assistance in dying is a deeply personal issue for all Canadians and must be addressed with the utmost compassion and empathy. It is critically important to monitor how the legislation is being implemented across the country to understand how the wishes of eligible patients are being carried out, and to protect the most vulnerable. Public reporting in this area is key to ensuring transparency and fostering public trust.

Today, the Government of Canada published final regulations in Canada Gazette, Part II that create a federal pan-Canadian monitoring system on medical assistance in dying. The regulations set out reporting requirements for physicians and nurse practitioners who receive written requests for medical assistance in dying, and for pharmacists who dispense medication for assisted dying. Any personal data collected will be protected under the federal Privacy Act.

The information will be used to publish annual reports on medical assistance in dying in Canada, including the number of requests received, the number of medically assisted deaths and the number of people found ineligible. The regulations come into force on November 1, 2018, and providers have until that date to become familiar with the new reporting requirements.

Health Canada expects to continue to produce interim reports until the permanent monitoring and reporting system is operational. Annual federal reporting using the data collected under the Regulations is expected to begin in 2019.

Quotes

"Medical assistance in dying is a sensitive, complex issue and many Canadians have deeply-held views on the subject. We are committed to ensuring that Canadians who choose medical assistance in dying have access to these services. These regulations promote transparency and will help us monitor how this service is being implemented across the country."

The Honourable Ginette Petitpas Taylor
Minister of Health

Quick Facts:

Related Products

 

SOURCE Health Canada


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: